AUROPHARMA

Aurobindo Pharma Share Price Aurobindo Pharma

₹1,076.95
50.55 (4.92%)
  • Advice
  • Hold
03 March, 2024 04:56 BSE: 524804 NSE: AUROPHARMAISIN: INE406A01037

Start SIP in Aurobindo Pharma

Start SIP

Aurobindo Pharma Performance

Day Range

  • Low 1,037
  • High 1,078
₹ 1,076

52 Week Range

  • Low 445
  • High 1,177
₹ 1,076
  • Open Price1,041
  • Previous Close1,026
  • Volume665407

Aurobindo Pharma Share Price

  • Over 1 Month 0.96%
  • Over 3 Month 4.18%
  • Over 6 Month 30.45%
  • Over 1 Year 132.65%

Aurobindo Pharma Key Statistics

P/E Ratio 22.8
PEG Ratio 0.6
Market Cap Cr 63,103
Price to Book Ratio 2.3
EPS 20.8
Dividend 0.4
Relative Strength Index 57.21
Money Flow Index 50.29
MACD Signal -11.64
Average True Range 32.85
Aurobindo Pharma Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 2,6642,6482,3643,484
Operating Expenses Qtr Cr 2,2102,1241,9682,856
Operating Profit Qtr Cr 482545422692
Depreciation Qtr Cr 646660115
Interest Qtr Cr 61373249
Tax Qtr Cr 6313090171
Net Profit Qtr Cr 624416336645
IndicatorMar 2023
Total Revenue Annual Cr 13,226
Operating Expenses Annual Cr 11,061
Operating Profit Annual in Cr 1,731
Depreciation Cr 435
Interest Annual Cr 115
Tax Annual Cr 384
Net Profit Annual Cr 1,230
IndicatorMar 2023
Cash from Operating Activity Annual Cr 1,821
Cash from Investing Activity Annual Cr -3,460
Cash from Financing Annual Activity Cr 1,719
Net Cash Flow Annual Cr 81
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 17,914
Fixed Assets Annual Cr 3,927
Total Non Current Assets Annual Cr 15,210
Total Current Assets Annual Cr 9,724
Total Assets Annual Cr 24,934
IndicatorMar 2023
Book Value Per Share Annual Rs 306
ROE Annual % 7
ROCE Annual % 9
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 17
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 7,2717,1516,7916,379
Operating Expenses Qtr Cr 5,7505,8465,6995,471
Operating Profit Qtr Cr 1,6011,3731,1511,002
Depreciation Qtr Cr 423418327346
Interest Qtr Cr 76685756
Tax Qtr Cr 322324242224
Net Profit Qtr Cr 936757571506
IndicatorMar 2023
Total Revenue Annual Cr 25,146
Operating Expenses Annual Cr 21,137
Operating Profit Annual in Cr 3,719
Depreciation Cr 1,245
Interest Annual Cr 140
Tax Annual Cr 685
Net Profit Annual Cr 1,928
IndicatorMar 2023
Cash from Operating Activity Annual Cr 2,387
Cash from Investing Activity Annual Cr -3,978
Cash from Financing Annual Activity Cr 1,814
Net Cash Flow Annual Cr 223
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 26,840
Fixed Assets Annual Cr 15,818
Total Non Current Assets Annual Cr 18,344
Total Current Assets Annual Cr 21,546
Total Assets Annual Cr 39,890
IndicatorMar 2023
Book Value Per Share Annual Rs 458
ROE Annual % 7
ROCE Annual % 10
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 16

Aurobindo Pharma Technicals

EMA & SMA

Current Price
₹1,076.95
50.55 (4.92%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹1,045.99
  • 50 Day
  • ₹1,049.78
  • 100 Day
  • ₹1,010.22
  • 200 Day
  • ₹912.87
  • 20 Day
  • ₹1,028.97
  • 50 Day
  • ₹1,077.22
  • 100 Day
  • ₹1,020.28
  • 200 Day
  • ₹899.95

Aurobindo Pharma Resistance and Support

PIVOT
₹1,063.94
Resistance
First Resistance 1,090.72
Second Resistance 1,104.48
Third Resistance 1,131.27
RSI 57.21
MFI 50.29
MACD Single Line -11.64
MACD -7.11
Support
First Resistance 1,050.17
Second Resistance 1,023.38
Third Resistance 1,009.62

Aurobindo Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,772,650 132,920,841 47.94
Week 1,993,768 86,788,712 43.53
1 Month 4,004,651 182,251,679 45.51
6 Month 2,579,750 113,947,552 44.17

Aurobindo Pharma Result Highlights

Aurobindo Pharma Synopsis

NSE-Medical-Generic Drugs

Aurobindo Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 12792.28 Cr. and Equity Capital is Rs. 58.59 Cr. for the Year ended 31/03/2023. Aurobindo Pharma Ltd. is a Public Limited Listed company incorporated on 26/12/1986 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1986PLC015190 and registration number is 015190.
Market Cap 60,141
Sales 11,299
Shares in Float 28.12
No of funds 759
Yield 0.44
Book Value 3.36
U/D Vol ratio 0.8
LTDebt / Equity
Alpha 0.27
Beta 0.53

Aurobindo Pharma

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 51.83%51.83%51.83%51.83%
Mutual Funds 14.7%11.27%8.37%7.64%
Insurance Companies 5.53%6.67%7.03%7.2%
Foreign Portfolio Investors 20.72%22.45%24.12%23.03%
Financial Institutions/ Banks
Individual Investors 5.65%6.16%7.02%8.54%
Others 1.57%1.62%1.63%1.76%

Aurobindo Pharma Management

Name Designation
Mr. K Ragunathan Non Exe.Chairman&Ind.Director
Mr. K Nithyananda Reddy Vice Chairman & Mng.Director
Dr. M Sivakumaran Whole Time Director
Mr. M Madan Mohan Reddy Whole Time Director
Mr. P V Ramprasad Reddy Non Executive Director
Mrs. Savita Mahajan Independent Director
Mr. Girish P Vanvari Independent Director
Dr.(Mrs.) Avnit Bimal Singh Independent Director
Mr. Santanu Mukherjee Independent Director

Aurobindo Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aurobindo Pharma Corporate Action

Date Purpose Remarks
2024-02-10 Quarterly Results & Interim Dividend
2023-11-09 Quarterly Results & Interim Dividend
2023-08-12 Quarterly Results
2023-05-27 Audited Results
2023-02-09 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-02-20 INTERIM Rs.1.50 per share(150%)Second Interim Dividend
2023-11-20 INTERIM Rs.3.00 per share(300%)First Interim Dividend
2023-02-17 INTERIM Rs.3.00 per share(300%)Interim Dividend
2022-06-07 INTERIM Rs.4.50 per share (450%) Fourth Interim Dividend
2022-02-21 INTERIM Rs.1.50 per share(150%)Third Interim Dividend

Aurobindo Pharma FAQs

What is Share Price of Aurobindo Pharma ?

Aurobindo Pharma share price is ₹1,076 As on 03 March, 2024 | 04:42

What is the Market Cap of Aurobindo Pharma ?

The Market Cap of Aurobindo Pharma is ₹63102.7 Cr As on 03 March, 2024 | 04:42

What is the P/E ratio of Aurobindo Pharma ?

The P/E ratio of Aurobindo Pharma is 22.8 As on 03 March, 2024 | 04:42

What is the PB ratio of Aurobindo Pharma ?

The PB ratio of Aurobindo Pharma is 2.3 As on 03 March, 2024 | 04:42

Is it a good time to invest in Aurobindo Pharma?

Aurobindo Pharma has an operating revenue of Rs.24,010.31 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 30% is great. Many brokers and analysts have recommended 'Buy' on the stock.

How many times have Aurobindo Pharma given dividends since 2000?

Aurobindo Pharma Ltd. has declared 40 dividends since May 10, 2000.

What is the stock price CAGR of Aurobindo Pharma?

The stock price CAGR of Aurobindo Pharma for 10 Years is 30%, 5 Years is 0%, 3 Years is -3%, 1 Year is -25%.

What is the ROE of Aurobindo Pharma?

Aurobindo Pharma has an ROE of 24% which is exceptional.

What is Aurobindo Pharma’s debt to equity?

Aurobindo Pharma has a reasonable debt to equity of 1%, which signals a healthy balance sheet.

Q2FY23